| Trial Identifier: | 0739-CL-0101 |
| Sponsor: | Astellas Pharma Global Development, Inc. |
| Start Date: | December 2021 |
| Primary Completion Date: | June 2023 |
| Study Completion Date: | June 2023 |
| Condition: | Cancer - Other; Lung Cancer; Ovarian Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| United States of America, CA | Duarte, CA, United States of America, 91010 |
| United States of America, FL | Miami, FL, United States of America, 33136 |
| United States of America, IL | Chicago, IL, United States of America, 60637 |
| United States of America, IL | Chicago, IL, United States of America, 60611 |
| United States of America, NY | New York, NY, United States of America, 10016 |
| United States of America, RI | Providence, RI, United States of America, 02903 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company